Log In
Print this Print this

Helixate FS, Helixate NexGen

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionRecombinant non-plasma derived Factor VIII
Molecular Target Factor VIII
Mechanism of ActionProcoagulant
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsTreat and prevent bleeding in patients with hemophilia A; Treat hemophilia A
Regulatory Designation
Partner Bayer AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today